Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-04-17 to 2024-04-18
Current total value of award: $2637.11
Description: 4564304739!QUILLIVANT XR ORAL SUSP 150ML 5MG/ML